After FACTS: What’s next for HIV prevention in women?
March 2015
Click for full info +After FACTS: What’s next for HIV prevention in women?
| 09 March 2015 |
In this Webinar:
Health Risk(s):HIV
Product Type(s):Vaginal Cream/Gel
Topic(s):Product Trials
Full Info:
Resource Type:
Citation:
Hosted by AVAC, this live webinar featured results from the FACTS 001 tenofovir gel study and its MPT potential, as well as discussed the open-label Partners Demonstration Project.
Authors: AVAC.
Health Risks(s):
- HIV
Product type(s):
- VaginalCream
Topic(s):
- Trials
URL of resource: